The Clinicopathological Significance of miR-133a in Colorectal Cancer

Disease Markers

Volumn 2014, Issue , 2014, Pages

  Wan, Timothy Ming Hun ^a   Lam, Colin Siu Chi ^a   Ng, Lui ^a   Chow, Ariel Ka Man ^a   Wong, Sunny Kit Man ^a   Li, Hung Sing ^a   Man, Johnny Hon Wai ^a   Lo, Oswens Siu Hung ^a   Foo, Dominic ^a   Cheung, Alvin ^a   Yau, Thomas ^a   Poon, Jensen Tung Chung ^a   Poon, Ronnie Tung Ping ^a   Law, Wai Lun ^a   Pang, Roberta Wen Chi ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; FASCIN; FASCIN 1; LIM PROTEIN; MICRORNA; MICRORNA 133A; PROTEIN SH3; SH3 DOMAIN PROTEIN 1; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; CARRIER PROTEIN; CAV1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; FSCN1 PROTEIN, HUMAN; LASP1 PROTEIN, HUMAN; MIRN133 MICRORNA, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER TISSUE; COLON MUCOSA; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; CORRELATION COEFFICIENT; CORRELATIONAL STUDY; DISTANT METASTASIS; FEMALE; GENE EXPRESSION; GENE TARGETING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATHOPHYSIOLOGY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; TISSUE SECTION; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; DOWN REGULATION; GENETICS; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; VERY ELDERLY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; CASE-CONTROL STUDIES; CAVEOLIN 1; COLORECTAL NEOPLASMS; CYTOSKELETAL PROTEINS; DOWN-REGULATION; FEMALE; HUMANS; INTESTINAL MUCOSA; LIM DOMAIN PROTEINS; MALE; MICROFILAMENT PROTEINS; MICRORNAS; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84904647875     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2014/919283     Document Type: Article

References (33)

1. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D., Global cancer statistics. CA Cancer Journal for Clinicians 2011 61 2 69 90 10.3322/caac.20107 2-s2.0-79952232216
2. Gaedcke J., Grade M., Camps J., Søkilde R., Kaczkowski B., Schetter A. J., Difilippantonio M. J., Harris C. C., Ghadimi B. M., Møller S., Beissbarth T., Ried T., Litman T., The rectal cancer microRNAome-microRNA expression in rectal cancer and matched normal mucosa. Clinical Cancer Research 2012 18 18 4919 4930 10.1158/1078-0432.CCR-12-0016 2-s2.0-84866364068
3. Oberg A. L., French A. J., Sarver A. L., Subramanian S., Morlan B. W., Riska S. M., Borralho P. M., Cunningham J. M., Boardman L. A., Wang L., Smyrk T. C., Asmann Y., Steer C. J., Thibodeau S. N., MiRNA expression in colon polyps provides evidence for a Multihit model of colon cancer. PLoS ONE 2011 6 6 e20465 10.1371/journal.pone.0020465 2-s2.0-79958270237
4. Tanaka T., Colorectal carcinogenesis: review of human and experimental animal studies. Journal of Carcinogenesis 2009 8, article 5 10.4103/1477-3163. 49014 2-s2.0-65449180675
5. Goel A., Boland C. R., Epigenetics of colorectal cancer. Gastroenterology 2012 143 6 1442.e1 1460.e1 10.1053/j.gastro.2012.09.032 2-s2.0-84869808619
6. Dong Y., Zhao J., Wu C. W., Zhang L., Liu X., Kang W., Leung W. W., Zhang N., Chan F. K., Sung J. J., Ng S. S., Yu J., MiR-133a activates the p53/p21 pathway and functions as a tumor suppressor in colorectal cancer by repressing RFFL. Molecular Cancer Research 2013 11 9 1051 1060 10.1158/1541-7786.MCR-13- 0061
7. Kozomara A., Griffiths-Jones S., MiRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Research 2011 39 1 D152 D157 10.1093/nar/gkq1027 2-s2.0-78651293534
8. Sarkar F. H., Epigenetics and Cancer 2013 Springer 10.1007/978-94-007- 6612-9
9. Chiyomaru T., Enokida H., Tatarano S., Kawahara K., Uchida Y., Nishiyama K., Fujimura L., Kikkawa N., Seki N., Nakagawa M., MiR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. British Journal of Cancer 2010 102 5 883 891 10.1038/sj.bjc.6605570 2-s2.0-77649271930
10. Kano M., Seki N., Kikkawa N., Fujimura L., Hoshino I., Akutsu Y., Chiyomaru T., Enokida H., Nakagawa M., Matsubara H., MiR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. International Journal of Cancer 2010 127 12 2804 2814 10.1002/ijc.25284 2-s2.0-77956181723
11. Zhao L., Wang H., Liu C., Liu Y., Wang X., Wang S., Sun X., Li J., Deng Y., Jiang Y., Ding Y., Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1. Gut 2010 59 9 1226 1235 10.1136/gut.2009. 202739 2-s2.0-77956130440
12. Wu Z., Wang C., Xiang R., Liu X., Ye S., Yang X., Zhang G., Xu X., Zhu T., Wu Q., Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion. BMC Cancer 2012 12, article 51 10.1186/1471-2407-12-51 2-s2.0-84862801756
13. Cui W., Zhang S., Shan C., Zhou L., Zhou Z., microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway. The FEBS Journal 2013 280 16 3962 3974 10.1111/febs.12398 2-s2.0-84879847735
14. Kojima S., Chiyomaru T., Kawakami K., Yoshino H., Enokida H., Nohata N., Fuse M., Ichikawa T., Naya Y., Nakagawa M., Seki N., Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer. British Journal of Cancer 2012 106 2 405 413 10.1038/bjc.2011.462 2-s2.0-84856454111
15. Nohata N., Hanazawa T., Kikkawa N., Mutallip M., Fujimura L., Yoshino H., Kawakami K., Chiyomaru T., Enokida H., Nakagawa M., Okamoto Y., Seki N., Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma. International Journal of Oncology 2011 38 1 209 217 10.3892/ijo-00000840 2-s2.0-78650825062
16. Williams T. M., Lisanti M. P., Caveolin-1 in oncogenic transformation, cancer, and metastasis. American Journal of Physiology: Cell Physiology 2005 288 3 C494 C506 10.1152/ajpcell.00458.2004 2-s2.0-13644266312 (Pubitemid 40229478)
17. Fine S. W., Lisanti M. P., Galbiati F., Li M., Elevated expression of caveolin-1 in adenocarcinoma of the colon. American Journal of Clinical Pathology 2001 115 5 719 724 10.1309/YL54-CCU7-4V0P-FDUT 2-s2.0-0035153475 (Pubitemid 33051539)
18. Bender F. C., Reymond M. A., Bron C., Quest A. F. G., Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Research 2000 60 20 5870 5878 2-s2.0-0034667394
19. Savage K., Lambros M. B. K., Robertson D., Jones R. L., Jones C., Mackay A., James M., Hornick J. L., Pereira E. M., Milanezi F., Fletcher C. D. M., Schmitt F. C., Ashworth A., Reis-Filho J. S., Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis. Clinical Cancer Research 2007 13 1 90 101 10.1158/1078-0432.CCR-06- 1371 2-s2.0-33846288318 (Pubitemid 46121857)
20. Li L., Yang G., Ebara S., Satoh T., Nasu Y., Timme T. L., Ren C., Wang J., Tahir S. A., Thompson T. C., Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells. Cancer Research 2001 61 11 4386 4392 2-s2.0-0035361376 (Pubitemid 32685764)
21. Ho C., Huang P., Huang H., Chen Y., Yang P., Hsu S., Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. The American Journal of Pathology 2002 161 5 1647 1656 10.1016/S0002-9440(10)64442-2 2-s2.0-0036841790 (Pubitemid 35265524)
22. Liu L., Xu H. X., Wang W. Q., Wu C. T., Chen T., Qin Y., Liu C., Xu J., Long J., Zhang B., Xu Y., Ni Q., Li M., Yu X., Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic cancer. Oncogene 2014 33 2728 2736 10.1038/onc.2013.223 2-s2.0-84878895939
23. Quann K., Gonzales D. M., Mercier I., Wang C., Sotgia F., Pestell R. G., Lisanti M. P., Jasmin J., Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide. Cell Cycle 2013 12 10 1510 1520 10.4161/cc.24497 2-s2.0-84877979838
24. Alshenawy H. A., Ali M. A., Differential caveolin-1 expression in colon carcinoma and its relation to E-cadherin-beta-catenin complex. Annals of Diagnostic Pathology 2013 17 6 476 482 10.1016/j.anndiagpath.2013.05.007
25. Wang H., An H., Wang B., Liao Q., Li W., Jin X., Cui S., Zhang Y., Ding Y., Zhao L., miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway. European Journal of Cancer 2013 49 18 3924 3935 10.1016/j.ejca.2013.07.149 2-s2.0-84881517082
26. Grunewald T. G., Butt E., The LIM and SH3 domain protein family: structural proteins or signal transducers or both? Molecular Cancer 2008 7, article 31 10.1186/1476-4598-7-31 2-s2.0-43049128509 (Pubitemid 351622380)
27. Kim M. Y., Oskarsson T., Acharyya S., Nguyen D. X., Zhang X. H., Norton L., Massagué J., Tumor self-seeding by circulating cancer cells. Cell 2009 139 7 1315 1326 10.1016/j.cell.2009.11.025 2-s2.0-72249093615
28. Vignjevic D., Schoumacher M., Gavert N., Janssen K., Jih G., Laé M., Louvard D., Ben-Ze'ev A., Robine S., Fascin, a novel target of β -catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Research 2007 67 14 6844 6853 10.1158/0008-5472.CAN-07-0929 2-s2.0-34547101481 (Pubitemid 47105531)
29. Chen M. B., Wei M. X., Han J. Y., Wu X. Y., Li C., Wang J., Shen W., Lu P. H., MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer. Cellular Signalling 2014 26 1 102 109 10.1016/j.cellsig.2013.07.017
30. Nohata N., Hanazawa T., Enokida H., Seki N., MicroRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers. Oncotarget 2012 3 1 9 21 2-s2.0-84860011976
31. Dallas N. A., Xia L., Fan F., Gray M. J., Gaur P., Van Buren G. II, Samuel S., Kim M. P., Lim S. J., Ellis L. M., Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Research 2009 69 5 1951 1957 10.1158/0008-5472.CAN-08-2023 2-s2.0-62449205665
32. Rossi L., Bonmassar E., Faraoni I., Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro. Pharmacological Research 2007 56 3 248 253 10.1016/j.phrs.2007.07.001 2-s2.0-34548215742 (Pubitemid 47321208)
33. Luo X., Stock C., Burwinkel B., Brenner H., Identification and evaluation of plasma microRNAs for early detection of colorectal cancer. PLoS ONE 2013 8 5 e62880 10.1371/journal.pone.0062880 2-s2.0-84877781097